HOME >> BIOLOGY >> NEWS
AAAS Cautiously Optimistic Of R & D Budget; Warns Of Slant Toward Health Research And Reliance On Tobacco Settlement

The significant increases in funding for R&D programs called for in President Clinton's FY 1999 budget proposal are encouraging, but uneven and heavily dependent upon revenues from an undetermined tobacco settlement, according to a preview of the annual budget analysis released today by the American Association for the Advancement of Science (AAAS).

The AAAS analysis raises concerns about the source of the increases slated for the National Institutes of Health (NIH), the National Science Foundation (NSF), and other R&D funding agencies. A major portion would come from the Research Fund for America, which will be built from tobacco settlement revenues. If a settlement is not reached, the White House may have to propose alternate funding sources for the increases, and may be forced to dip into the budget surplus, go beyond the spending caps, or reallocate money intended to fund other programs.

Another concern in the report is that the bulk of the increases in the President's proposal will support health and life science programs. According to the AAAS analysis, these programs often depend upon the research successes in the physical sciences, engineering and mathematics -- areas which are not slated for major increases. Increases in nondefense R&D are concentrated among only three agencies -- NIH, NSF, and the Department of Energy (DOE).

The AAAS analysis indicates that the President's budget request includes a 2.2 percent or $1.7 billion increase for R&D over the current FY 1998 funding level. After adjusting for inflation, the request represents a slight overall increase of less than one percent. In 1999, nondefense R&D would increase by 5.1 percent to $37.4 billion, while defense R&D would decrease by 0.3 percent to $40.3 billion.

"While the proposal is a positive one, and we are optimistic about it, it's neither balanced or straightforward," said Al Teich, director of the AAAS
'"/>

Contact: Ellen Cooper
ecooper@aaas.org
202-326-6434
American Association for the Advancement of Science
21-Apr-1998


Page: 1 2

Related biology news :

1. Towards an AIDS vaccine: unusual antibody that targets HIV described by scientists at TSRI
2. Scientists Make Progress Toward Gene Therapy For HIV Infection
3. Structure Of Tumor Necrosis Factor-Alpha-Converting Enzyme Solved - Milestone Toward Rational Drug Design For Rheumatoid Arthritis And Endotoxic Shock
4. Towards A Local Stimulation Of Natural Bypass Growth - Max Planck Scientists Developed New Treatment For Ischemic Heart Disease
5. Researchers Take Major Step Toward Cracking Ebola Code
6. Health of worlds sea lions the focus of Wakefield Symposium
7. OneWorld Health compiles comprehensive state of infectious diarrhea treatments, potential solutions
8. Institute for OneWorld Health nominated for the 2004 World Technology Awards
9. Healthy fats and oils essential to satisfy calorie-conscious consumers
10. Institute for OneWorld Health receives Gates Foundation grant
11. Donaghue Womens Health Investigator Program awards grants to three at Yale

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/12/2019)... ... November 12, 2019 , ... ... in the design and manufacturer of technical ergonomic seating solutions, announced this ... compliant with Healthier Hospital Initiative guidelines. Established by Practice Greenhealth, a health ...
(Date:11/9/2019)... , ... November 08, 2019 , ... SiteSeer Technologies, creator ... as a new client and user of SiteSeer. The boutique real estate developer ... the U.S. will use SiteSeer to supplement its own analysis of markets. , ...
(Date:11/6/2019)... ANN ARBOR, Mich. (PRWEB) , ... November 06, ... ... of Mastermind® version 2.0 today. The Genomic Search Engine now includes ... This new functionality will further accelerate diagnosis of patients with genetic and rare ...
Breaking Biology News(10 mins):
(Date:11/5/2019)... , ... November 04, 2019 ... ... of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene ... cell line development technology, GPEx® Boost. The technology enhances Catalent’s proven GPEx ...
(Date:11/2/2019)... ... October 31, 2019 , ... drug360 graph, a breakthrough knowledge ... drug360 brings tellic’s expertise in biomedical language processing and machine learning to bear ... between genes, diseases, variants, phenotypes, and other biomedical entities. Researchers and analysts ...
(Date:10/29/2019)... ... October 29, 2019 , ... Researchers at Sony recently demonstrated ... multispectral imagers , researchers identified people by the image of a small patch ... face recognition, fingerprints and vasculature. , The new CMS4 series of cameras ...
(Date:10/22/2019)... ... 2019 , ... DermBiont, a clinical stage microbiome biotechnology company ... primary safety endpoints, with no application site reactions and no adverse events, in ... interdigital tinea pedis (athlete’s foot). Additionally, the trial demonstrated a clinical response with ...
Breaking Biology Technology:
Cached News: